Clinical Trials Logo

Behavior, Addictive clinical trials

View clinical trials related to Behavior, Addictive.

Filter by:

NCT ID: NCT03706937 Completed - Clinical trials for Paramedical Professional

The Treatment of Addictions in the Course of Care in Oncology: an Inventory of Fixtures Among Paramedical Professionals

PREFACE
Start date: October 1, 2018
Phase:
Study type: Observational

Nowadays, guidance is given on the implementation of innovative approaches to promote autonomy and user participation through strategies designed to strengthen the patient's empowerment. [SNS 2018-2022, Ministère des Solidarités et de la Santé] The 2014-2019 Cancer Plan calls for the systematic support of smokers during smoking cessation. This means that health workers need to be trained to help with smoking cessation, as well as the motivational attitude that reinforces the patient's smoker's self-esteem as well as his desire to off-load this addiction. [Perriot, Underner, Peiffer, Dautzenberg, 2018] It is recommended that these interventions be included from the beginning of the management, once the diagnosis of Cancer is made. It seems legitimate then to wonder about the place of choice the Motivational Interview (EM) could have in the course of cancer care, for the management of addictions during the treatment of cancer. We therefore wish to carry out descriptive qualitative research in the Lucien Neuwirth Oncology Institute in order to try to define the management of addictions in the oncology care course. Thus, an approach in terms of social representations among paramedical professional actors involved in the care of patients treated for cancer and with an unresolved addictive disorder sounds the best way for this research.

NCT ID: NCT03694327 Completed - Smoking Cessation Clinical Trials

Innovative Digital Therapeutic for Smoking Cessation

Start date: October 24, 2018
Phase: N/A
Study type: Interventional

This study is comparing the efficacy of two smoking cessation apps.

NCT ID: NCT03685162 Completed - Opioid Addiction Clinical Trials

Observational Study to Evaluate Levomethadone Safety and Effectiveness in Subjects Under Opioid Maintenance Treatment

LEVOPROACT
Start date: February 27, 2018
Phase:
Study type: Observational

Multicentre, prospective, observational, non-interventional, open- ended trial, collecting data from male and female patients aged ≥ 18 years, with a diagnosis of opioid addiction according to ICD-10 (F11.2), treated with therapeutic doses of levomethadone according to the routine medical practice.

NCT ID: NCT03678051 Completed - Clinical trials for Substance Use Disorders

CBT4CBT for Women in Residential Treatment for Substance Use Disorders

Start date: October 4, 2018
Phase: N/A
Study type: Interventional

This project examines computer-delivered cognitive-behavioral intervention (CBT4CBT) as an adjunct to residential treatment for women with substance use disorders (SUD). The project will conduct a 2-arm randomized clinical trial (RCT) comparing post-discharge relapse rates for treatment as usual (TAU) with access to the CBT4CBT program vs. TAU in a residential sample of women with SUDs.

NCT ID: NCT03674970 Completed - Smoking Cessation Clinical Trials

Effects of Random Nicotine Delivery on Smoking Cessation

Start date: March 12, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to determine whether treatment with random nicotine delivery via a nicotine film both before and after the target quit date will facilitate smoking cessation relative to treatment with steady state delivery or placebo. The investigators hypothesize that smoking cessation will be greater in subjects assigned to a random nicotine delivery regimen (as compared to those assigned to a steady state or placebo regimen). The nicotine film product is not part of the standard of care and is not available in non-investigational settings in the United States.

NCT ID: NCT03651869 Completed - Smoking, Tobacco Clinical Trials

Effects of Nicotine in Tobacco Smokers

Start date: February 4, 2019
Phase: Phase 1
Study type: Interventional

This study will examine mechanisms linking Obsessive-Compulsive Disorder symptomatology to tobacco dependence.

NCT ID: NCT03583138 Completed - Clinical trials for Human Immunodeficiency Virus

HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

Start date: June 23, 2014
Phase:
Study type: Observational

STRIDE2 is a longitudinal, non-randomized study of individuals living with HIV who are dependent on opioids. This study is funded by the National Institute on Drug Abuse (R01DA030768, Altice, PI; Taxman & Lawson, Co-PIs) and is being conducted by George Mason University, Yale University, and Howard University.

NCT ID: NCT03483220 Completed - Addiction Clinical Trials

Emotional Regulation, Impulsivity in Cannabis Its Relation to MRI Brain Structure

Start date: March 1, 2021
Phase:
Study type: Observational

cannabis addiction is a major health hazard that has its effect on personality and behavior including the impulsivity and emotional regulation. It also has its effect on both the structure and function of different brain regions involved in brain reward system. the aim of the study is to study the emotional regulation and impulsivity among people with cannabis addiction studying the change in the volume of brain reward system structures' volume in relation to cannabis addiction and the change in the mentioned behavioral traits.

NCT ID: NCT03471182 Completed - Cocaine Dependence Clinical Trials

Investigation of Cocaine Addiction Using mGluR5 PET and fMRI

Start date: February 26, 2018
Phase: Phase 1
Study type: Interventional

The proposed research program will investigate the changes in brain chemistry and circuitry that 're-wire' the brain during chronic cocaine use, promote relapse, and complicate treatment efforts. Currently-using and non-treatment-seeking individuals with a cocaine use disorder will undergo a cocaine self-administration paradigm 2-5 days prior to completing positron emission tomography (PET) and functional magnetic resonance imaging (fMRI).

NCT ID: NCT03454711 Completed - Obesity Clinical Trials

Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway

AddictO
Start date: April 26, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

Identification of the cerebral fMRI phenotype of obese patients with FA in cognitive task context based on food choice making